TY  - GEN
AU  - Takano,Shigetsugu
AU  - Togawa,Akira
AU  - Yoshitomi,Hideyuki
AU  - Shida,Takashi
AU  - Kimura,Fumio
AU  - Shimizu,Hiroaki
AU  - Yoshidome,Hiroyuki
AU  - Ohtsuka,Masayuki
AU  - Kato,Atsushi
AU  - Tomonaga,Takeshi
AU  - Nomura,Fumio
AU  - Miyazaki,Masaru
TI  - Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy
SN  - 1534-4681
PY  - 2009///0129
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Aged
KW  - Annexin A2
KW  - genetics
KW  - Antimetabolites, Antineoplastic
KW  - therapeutic use
KW  - Blotting, Western
KW  - Carcinoma, Adenosquamous
KW  - Carcinoma, Pancreatic Ductal
KW  - Cell Survival
KW  - drug effects
KW  - Chemotherapy, Adjuvant
KW  - Deoxycytidine
KW  - analogs & derivatives
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Immunoenzyme Techniques
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Invasiveness
KW  - Neoplasm Recurrence, Local
KW  - diagnosis
KW  - Pancreatic Neoplasms
KW  - Prognosis
KW  - RNA, Messenger
KW  - RNA, Small Interfering
KW  - pharmacology
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Survival Rate
KW  - Tumor Cells, Cultured
KW  - Gemcitabine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1245/s10434-008-0061-5
ER  -